Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Anturol
Anturol
7 FDA Decisions You Can't Afford to Ignore in Q4
Motley Fool
Sat, 10/15/11 - 11:39 am
Bristol-Myers Squibb
Dapagliflozin
BioSante
Bio-T-Gel
Regeneron
Eylea
Transcept
Intermezzo
Incyte
ruxolitinib
Antares
Anturol
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Antares Pharma Inc. (AIS) Gets New Drug Application Approval from FDA
Favstocks
Sat, 04/9/11 - 11:38 am
Antares
overactive bladder
Anturol